Laxmi Organic Industries Q2FY26 Concall Decoded: “The Chemical Cocktail of Hope and Hangovers”
Date of Publishing -
Spotted a factual error — a wrong number, date, or fact? Tell us and we will check the source.
1. Opening Hook
In a world where chemical stocks react faster than bromine, Laxmi Organic’s Q2FY26 call was part sermon, part survival tale. Global overcapacity? Check. Supply chain rerouting? Double check. Management’s optimism? Off the charts. Like Arjuna focusing on the eye of the fish, Dr. Rajan insists on cost discipline amid chaos — but this fish is swimming in a tank full of ethyl acetate. Stick around — the real alchemy begins when you mix fluorine dreams with fiscal reality. ☠️
2. At a Glance
Revenue down 9% – Apparently “decline” now means “in line with expectations.”
EBITDA at ₹37 Cr (↓50%) – CFO calls it “stable.” Investors call it something else.
Margins at 5.3% (vs 9.7%) – Squeezed harder than a lemon in a chemical wash.
PAT at ₹11 Cr (vs ₹28 Cr) – Typo turned ₹110 Cr fantasy, later clarified. Dreams are free.
Cash Flow ₹153 Cr – Still breathing thanks to working capital yoga.
Debt/Equity 0.17x – Cleaner than a lab coat, for now.
3. Management’s Key Commentary
“Global chemical industry remains demanding with overcapacity and cost pressures.” (Translation: Everyone’s making too much stuff; we’re all broke together.)
“Specialty business declined 20% due to phase-out of one agrochemical product.” (Translation: Our ‘specialty’ took a specialty hit.)
“Deferred deliveries will move to H2, so expect a rebound.” (Translation: Please don’t dump the stock just yet 😅.)
“Fluorine setup ramping as planned; 40–50% of peak revenue expected this year.” (Translation: Still in the lab, but the flask is bubbling.)
“Capex of ₹1,100 Cr remains on track, funded prudently.” (Translation: We’re spending big, but let’s call it ‘vision’.)
